1. Phosphoenolpyruvate carboxykinase was assayed by three methods: (i) incorporation of H14CO3-into oxaloacetate: (ii) conversion of oxaloacetate into phosphoenolpyruvate, subsequently assayed enzymically; and (iii) transfer of 32p from [y-32P] GTP to oxaloacetate. 2. Enzyme activity is increased in liver and epididymal adipose tissue in alloxandiabetes and starvation, and in kidney in starved, acidotic and steroid-treated animals. 3. The ratios of the 'back' to the 'forward' reactions in liver, kidney and epididymal adipose tissue are different and characteristic of each tissue; they differ markedly from values reported for the purified mitochondrial enzyme. 4. The ratio of the 'back' to 'forward' reaction in any one tissue is constant in adrenalectomized, diabetic, acidotic and steroidtreated animals. 5. In starved animals, the ratio is increased in liver and kidney, but decreased in epididymal adipose tissue. 6. Administration of L-tryptophan results in an acute (1 h) increase in activity measured in the 'forward' direction alone in liver and epididymal adipose tissue, but not in kidney.
There is now substantial evidence that phosphoenolpyruvate carboxykinase [GTP-oxaloacetate carboxy-lyase (transphosphorylating), EC 4.1.1.32] plays an important role in the regulation of gluconeogenesis in mammalian systems (Record et al., 1972; Ui et al., 1973) . Nevertheless, studies of the mechanisms in which phosphoenolpyruvate carboxykinase may be involved have raised many problems. As an example, the published Km values for oxaloacetate (see Table 1 ) vary considerably from one report to another, and, in the case of the higher values, may not easily be reconciled with both the observed concentrations of oxaloacetate in tissues (Utter & Kolenbrander, 1972) and therates of glucose synthesis.
Some, at least, of these problems may have arisen from the absence of any simple, generally applicable, continuous assay system for phosphoenolpyruvate carboxykinase. As a result of this, a number of widely differing 'stopped' procedures have been developed. Since the conditions under which the various assays are performed are so diverse, simple numerical comparison between the systems is both difficult and suspect; the situation is particularly complicated by the fact that the enzyme has been measured in vitro in both the forward (i.e. conversion of oxaloacetate into phosphoenolpyruvate) and backward (phosphoenolpyruvate into oxaloacetate) directions, and that these measurements may not be readily interconverted. To our knowledge, only one study of the relative rates of the reaction in both directions Vol. 152 has been performed with purified enzyme. This study, with phosphoenolpyruvate carboxykinase from pig liver mitochondria, indicates that the relative maximum rates of the forward and backward reactions are 8.3 :1, 11.3 :1 and 18.5:1, at pH 6. 8, 7.3 and 8.0 respectively (Chang etal., 1966) . A brief survey of the literature, however, reveals that these ratios may not necessarily be reflected in measurements in unpurified tissue extracts (see, e.g., Scrutton & Utter, 1968; Meyuhas et a!., 1971; Williamson et al., 1971; Utter, 1971) . In the present paper we report a systematic investigation of phosphoenolpyruvate carboxykinase activities in rat tissues as assayed by three independent methods. These studies have been extended to conditions in which gluconeogenic flux is modified by various agents, namely starvation, diabetes and tryptophan in the liver, starvation and NH4Cl-induced acidosis in the kidney. We have also included measurements on adipose tissue phosphoenolpyruvate carboxykinase, which may be important in glyceride glycerol synthesis (Hanson et al., 1973) , and/or as a necessary enzyme for the return of cytoplasmic oxaloacetate to the mitochondrion during fat synthesis from certain substrates (Martin & Denton, 1970) .
The ratios of the forward and backward reactions are at variance with those derived from the earlier data with purified enzyme, are characteristic of each of the three tissues examined, and are, in general, little affected by treatments that alter total phosphoenolpyruvate carboxykinase activity.
Materials and Methods Chemicals and enzymes
Tris, 2-mercaptoethanol, dithiothreitol, cycloheximide and Tween 80 were from Sigma (London) Chemical Co. (Norbiton, Surrey, U.K.). Imidazole and 5-(4-biphenylyl)-2-(4-t-butylphenyl)-1-oxa-3,4-diazole were from Koch-Light Laboratories Ltd. (Colnbrook, Bucks., U.K.), and Norit GSX was from Norit Clydesdale Co. (Glasgow, U.K.).
NaH"4CO3 and [y-32P]GTP were obtained from The Radiochemical Centre, Amersham, Bucks., U.K.
ATP, GTP, oxaloacetic acid, GSH, NADH and all enzymes were purchased from Boehringer Corp. (London) Ltd., Lewes, Sussex, U.K. Phosphoenolpyruvate (monocyclohexylammonium salt) was prepared as described by Clark & Kirby (1966) . ITP was made by treatment of ATP with HNO2 as described by Kaplan (1957) 
Animals
Male Wistar rats (180-250g) were used throughout. Unless otherwise stated, all animals were allowed access to diet (no. 1 maintenance diet, Cooper Nutrition Products Ltd., Witham, Essex, U.K.) and water ad libitum.
Adrenal glands wereremoved by means ofa midline dorsal incision under diethyl ether anaesthesia. Adrenalectomized animals were given 1 % NaCI in place of water, and were left for 5-8 days before use. Diabetes was induced by intravenous injection of alloxan (60mg/kg body wt.). Animals were used after 2 days; hyperglycaemia was confirmed enzymically (Huggett & Nixon, 1957) . Rats were made acidotic by the oral administration of 0.4M-NH4CI (2.5mi/kg body wt.). The procedure was repeated after 12h, and animals were killed at 24h. Controls throughout received an equivalent volume of 0.4M-NaCl. Acidotic animals were given 0.18% NaCI in place of drinking water.
Appropriate dilutions of triamcinolone acetonide in 0.9 % NaCl were administered intraperitoneally (5 mg/kg bodywt.) atzero timeand 12h. Theseanimals were killed at 24h, together with the appropriate saline-treated controls. L-Tryptophan suspension (40mg/ml in 0.1 % Tween 80, 0.9 % NaCl) was injected intraperitoneally through a 16-gauge needle (dosage 0.8 g/kg body wt.); controls received a similar volume of the suspending medium. Animals were killed 1 h after injection. Cycloheximide (0.5mg/ml in 0.9% NaCI) was injected intraperitoneally at a dose of 1mg/kg body weight, 30min before each oral administration of NH4CL.
Preparation of extracts Animals were bled after decapitation. Tissues were removed, rinsed in ice-cold 0.9% NaCl, blotted gently, weighed and extracted in either 3 (fatpads) or 10 (liver, kidney) ml of 0.25M-sucrose5mM-Tris-HCl-1 mM-2-mercaptoethanol (pH 7.4)/g of tissue, by using a motor-driven all-glass homogenizer (Kontes Glass Co., Vineland, N.J., U.S.A.). This procedure ensures complete breakage of both whole cells and mitochondria. Suitable portions were centrifuged at 12000g for 8min in an Eppendorf 3200 centrifuge; theresulting supernatants were stored on ice until assay (0-5h).
Assay ofphosphoenolpyruvate carboxykinase (i) H'4C03-incorporation into oxaloacetate (Ballard & Hanson, 1967) The medium contained 0.1 Mimidazole, 2mM-MnCI2, 1 mM-dithiothreitol, 50mM-KHCO3 (containing 2,uCi of NaH14CO3), 1.5mM-phosphoenolpyruvate, 1 .25mM-IDP, 0.5mM-NADH, malate dehydrogenase (EC 1.1.1.37, 2.5,ug/ml) and extract, final pH 7.0, volume 1 .Oml. The reaction was started by the addition of extract, after 2min preincubation of medium. Samples, in duplicate, were incubated at 37°C for 10min; the reaction was stopped with 0.5 ml of 10% (w/v) trichloroacetic acid. After CO2 has been bubbled through each sample for at least 3min, 0.5ml portions were removed for radioactivity counting [scintillator:
The time-course of the reaction was linear throughout.
(ii) Conversion ofoxaloacetate intophosphoenolpyruvate (Seubert & Huth (1965) . The medium contained 0.1 M-Tris-HCI, 18mM-MgCI2, l5mM-NaF, 6mM-ITP, 1 mM-GSH, 4.5mM-oxaloacetate and extract, final pH 8. (1971) . The medium contained 20mM-Tris-HCI, 4mM-NaF, 5mM-MgCl2, 0.1 mM-GSH, 1 mM-oxaloacetate, 0.1 mM_y-32P]GTP (0.20Ci) and extract in a final volume of 0.2ml, pH8.0. The reaction was started by the addition of extract after 2min preincubation of medium. Samples were assayed in triplicate, and were incubated at 37°C for both 2 and 4min. The reaction was terminated by the addition of 1.Oml of 0.2M-HCIO4 containing 0.2mM-NaH2PO4; tubes were subsequently kept at 0°C. To each sample were added sequentially 1ml of 2% (w/v) ammonium molybdate containing 50mM-triethylamine hydrochloride, 0.2ml of Norit GSX (50mg/ml in water) and 5,u1 of 30mM-phosphoenolpyruvate. After 10min tubes were centrifuged at 1200g for 4min. Then 1.5ml portions of supernatants were added to 1.5ml of 0.25M-HgCl2; after 45min, 20,u1 of 0.16M-triethylamine hydrochloride-10mM-NaH2PO4 was added, and the tubes were left for a further 30min. After centrifugation, the supernatants were carefully removed by aspiration, and the pellets washed with 3x2ml of 0.2M-HCIO4-0.5% (w/v) ammonium molybdate-5OmM-triethylamine hydrochloride. The precipitates were finally dissolved in 10ml of scintillator and counted for radioactivity as described above. Blanks without enzyme or oxaloacetate were carried through the same procedure. Reaction rates were linear with time.
Results and Discussion
Assay systems Three assay systems were used as a routine. The conversion of phosphoenolpyruvate into oxaloacetate ('back' reaction) was measured by the widely used method of , as modified by Ballard & Hanson (1967) . The 'forward' reaction, in the physiological direction of phosphoenolpyruvate synthesis, was measured in two ways. The first, that of Seubert & Huth (1965) , has again been widely used and involves conditions under which the Km, value for oxaloacetate is high (Holten & Nordlie, 1965) , although lower values have also been reported (Ballard, 1970) . The second, modified from that devised by Walsh & Chen (1971) , and based on the transfer of 32p from [32PJGTP to oxaloacetate, is both more sensitive and gives the lowest Km values reported for oxaloacetate (Table 1) .
Preliminary experiments revealed that the dependence of enzyme activity on ionic composition was different in the 'forward' and 'back' reactions. Maximum rates were attained under standard assay conditions; the replacement of Mg2+ by Mn2+ in the Seubert & Huth (1965) 'forward' assay, and of Mn2+ by Mg2+ in the 'back' assay, resulted in substantially lower rates in both cases. The inclusion of NaF, at up to 15mM, was without effect throughout. The replacement of inosine nucleotide by guanine nucleotide in the same two assays again produced somewhat lower than maximum activities.
In the 32P assay, oxaloacetate concentrations were maintained at saturating values (1 nlim). An increase in the concentration of GTP from 0.1 to 2.Omm led to a 30-70% increase in rate. It is difficult, however, Guder & Schmidt (1974) (Ballard & Hanson, 1967) ; (B) 'forward' direction, 32p incorporation (modified from Walsh & Chen, 1971 ); (C) 'forward' direction, spectrophotometric assay (Seubert & Huth, 1965 The activities for any one tissue under one set of assay conditions agree withthe available values in the literature. At the same time, the data diverge markedly from expected values with respect to the relative rates of the 'back' and 'forward' reactions. For example, the 'back'/'forward' ratio in liver (A/C, see Table 2 ) is 0.60±0.03; this compares with an expected value of approx. 0.09 The ratios obtained from any two of the three assay methods are reproducible in each tissue examined, but vary between tissues. Thus the ratio of the rates in the "4C02-fixation and 32P-transfer systems (A/B) is twice as high in the kidney as in the liver, and that in adipose tissue is consistently higher again (Table 2) . Similarly, significant, although smaller, differences are seen between liver and kidney when the 'forward' reaction is measured by the Seubert & Huth (1965) method. The relatively lower sensitivity of this latter method unfortunately precludes its application for similar measurements in adiposetissue extracts.
Phosphoenolpyruvate carboxykinase activity in various dietary and hormonal states
The effects of steroid imbalance on phosphoenolpyruvate carboxykinase activities are demonstrated in Table 3 . Adrenalectomy has no effect on enzymic activity in the liver, as previously noted by Reshef et al. (1969) . Corticosteroids have been reported variously both to increase (Foster et al., 1966a (Foster et al., , 1967 Suda et al., 1973) and to decrease (Reshef et al., 1969) hepatic phosphoenolpyruvate carboxykinase. In the present study, we have observed that little significant change occurs with two assay systems, but that there is a fall in activity in the liver when the 32P assay method is used. It is probable that the variability of response after steroid administration is related to a number of extraneous factors, such as the source, age and weight of animals as well as the composition of diet and nutritional status.
In kidney, adrenalectomy leads to a significant decrease in phosphoenolpyruvate carboxykinase activity; the degree of 'repression' is similar in all three assay systems, so that ratios between these remain constant. Triamcinolone produces a substantial increase, again independent of the assay system used; this agrees with the data of Longshaw et al. (1972) . Conversely, adrenalectomy increases phosphoenolpyruvate carboxykinase activity in adipose tissue; this correlates with the fall that occurs after administration of triamcinolone.
Although total enzyme activity is altered by a number of hormonal changes (Tables 3 and 4) , the ratios of the 'back'/T'forward' reactions remain essentially constant. Thus acute alloxan-diabetes increases phosphoenolpyruvate carboxykinase activity in both liver and adipose tissue, but the corresponding changes in the ratios are not significant.
The activity in kidney is likewise increased, but to a lesser extent. Experimental 'chronic' diabetes is reported to cause somewhat greater increases (Anderson & Stowring, 1973; Murphy & Anderson, 1974) ; Vol. 152 this has been attributed to the prevailing ketoacidosis rather than to insulin deficiency itself (Kamm et a!., 1974) . In other experiments (not shown) we have found that acute alloxan-diabetes (48h) is associated variously with insignificant or barely significant increases in kidney enzyme activity.
Overnight starvation increases the 'back' reaction disproportionately to the 'forward' reaction in both liver and kidney, but produces an opposite effect in epididymal adipose tissue (Table 4 ). The mechanism and significance of these changes are unknown but it seems from the other data that changes in the concentrations of circulating insulin and corticosteroids are not involved.
L-Tryptophan increases total hepatic phosphoenolpyruvate carboxykinase activity and simultaneously and paradoxically, inhibits gluconeogenic flux at this reaction (Foster et al., 1966b; Ray et al, 1966) . The long-term increase in enzyme activity corresponds to an inhibition of specific degradative processes by tryphophan and a concomitant rise in enzyme protein (Ballard & Hopgood, 1973) . The increase in assayable phosphoenolpyruvate carboxykinase after 1 h is, however, not blocked by either transcription or translation inhibitors and has been attributed to activation of pre-existing enzyme (Foster et a!., 1966a (Foster et a!., , 1967 . This short-term increase may only be observed in the 'forward' direction (Williamson et a!., 1971; Ballard & Hopgood, 1973) ; the actinomycin D-sensitive rise over a longer timeperiod is, however, measurable in both directions. Expt. (III) in Table 4 confirms these earlier findings, although a small increase in the 'back' reaction is detectable. The ratios of the 'back' to the 'forward' reactions are markedly decreased; the percentage increases measured by the 'forward' assay methods are similar, the ratio of the two being unchanged. Phosphoenolpyruvate carboxykinase in kidney is markedly less sensitive to tryptophan administration; this correlates with the absence of tryptophan 2,3-dioxygenase (EC 1.13.11.11), obligatory for the conversion of tryptophan into quinolinate, in this tissue (Rose, 1972) . Adipose tissue, however, resembles liver in sensitivity towards tryptophan.
The phosphoenolpyruvate carboxykinase activity in kidney, but not liver, is increased by NH4Cl-induced acidosis (Alleyne & Scullard, 1969; . Table 5 shows that the activity is increased similarly, but not identically, in both 'back' and 'forward' directions. The effective inhibition by cycloheximide suggests that protein synthesis de novo is required for the increase in enzyme activity. It is clear that the rise in total phosphoenolpyruvate carboxykinase activities seen in livers and kidneys from animals treated variously as above correlates well with increases in gluconeogenic flux, and provides further circumstantial evidence for the role (Kamm & Cahill, 1969; Exton 1972) . Glucocorticoid, which facilitates gluconeogenesis in both tissues (Exton et al., 1970; Stumpf et al., 1972) , increases phosphoenolpyruvate carboxykinase concentrations in both tissues. Hanson et al. (1973) Longshaw & Pogson, 1972) , and presumably reflect the presence in all tbree tissues of a single protein species. The observed ratios therefore must be a reflexion rather of specific tissue factors than of the enzyme itself.
Although modification of enzymic activity can never alter the ultimate equilibrium position, it is theoretically permissible for an inhibitor or other modifying agent to affect the reaction velocity in one direction alone. Thismay for example, involve changes in substrate-binding constants or more complex events leading to altered reaction mechanisms. An example of this is already known in the case of phosphoenolpyruvate carboxykinase, in that quinolinate is an inhibitor in the physiological ('forward') direction alone (Ballard & Hopgood, 1973; Williamson et al., 1971) . Further, the paradoxical increase in enzyme activity in liver extracts from quinolinateor tryptophan-treated animals is also a unidirectional effect. It is difficult to fit a simple explanation to these observations. Snoke etal. (1971) have, however, drawn attention to the capacity of quinolinate to chelate Fe2+, an ion which stimulates phosphoenolpyruvate carboxykinase activity in vitro, and have proposed that changes in the ionic environment may be involved in the regulation of the enzyme in vivo.
Since tryptophan administration is associated with a fall in the ratio of the 'back' and the 'forward' reaction in liver and adipose tissue, it is possible that the higher ratio normally found in kidney and adipose tissue is due tosimilar binding of some as yet unknown effector. The tissue-dependent variable binding of such a ligand therefore offers one plausible explanation of the observations in this paper.
The increase in gluconeogenesis in livers perfused with glucagon may originate at the phosphoenolpyruvate carboxykinase reaction (Ui et al., 1973) . The possibility of a direct connection between raised cyclic AMP concentrations and phosphoenolpyruvate carboxykinase activity has been investigated, but nd positive evidence has been, found to Wicks et al., 1972) . Further, extensive jnvestigations with the purified enzyme designed to discover potential physiological effectors have been markedly unsuccessful (Foster et at., 1967; Utter & Kolenbrander, 1972) .
Although phosphoenolpyruvate carboxykinases from lower eukaryotes are apparently totrameric (Cannata, 1970; Diesterhaft et aL., 1972) , the mammalian forms so far purified to homogeneity are monomers of approx. 70000 molecular weight . Antibody to purified rat phosphoenolpyruvate carboxykinase titrates similarly against crude extracts and pure antigen; this is consistent with the presence of the monomeric form in normal tissue homogenates . There are, however, indications that higher-molecular-weight species may also occur in vivo (Longshaw & Pogson, 1972) ; if present, these species must possess structures such that monomers are readily produced during the homogenization process, presumably either by dissociation alone or by removal of covalently bound groups followed by dissociation. This work was supported by grants from the British Diabetic Association and the Medical Research Council.
